Filter News
Area of Research
- (-) Functional Materials for Energy (1)
- (-) Isotopes (4)
- Biology and Environment (21)
- Clean Energy (41)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Fusion and Fission (6)
- Isotope Development and Production (1)
- Materials (48)
- Materials Characterization (1)
- Materials for Computing (5)
- Materials Under Extremes (1)
- National Security (10)
- Neutron Science (18)
- Nuclear Science and Technology (2)
- Sensors and Controls (1)
- Supercomputing (20)
News Type
News Topics
- (-) Biomedical (3)
- (-) Grid (1)
- (-) Materials Science (2)
- (-) Security (1)
- Artificial Intelligence (1)
- Buildings (1)
- Climate Change (1)
- Computer Science (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (2)
- Frontier (1)
- High-Performance Computing (1)
- Isotopes (14)
- Machine Learning (1)
- Materials (3)
- National Security (1)
- Nuclear Energy (1)
- Simulation (1)
- Space Exploration (1)
- Sustainable Energy (1)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.